#22. Molecular Glue Degraders

from Drug Discovery AI Talk · host Dr. Jake Chen

This episode introduces molecular glue degraders (MGDs), an exciting class of targeted protein degraders that catalytically eliminate disease-causing proteins, including those once considered “undruggable.” We explain how MGDs function by promoting proximity between E3 ligases and target proteins, triggering their destruction via the ubiquitin-proteasome system. The conversation highlights the growing role of artificial intelligence in accelerating MGD discovery—ranging from virtual screening and generative drug design to structural modeling of ternary complexes and phenotypic screening analysis. Finally, the episode explores therapeutic opportunities in cancer, neurodegenerative, autoimmune, and infectious diseases, underscoring how AI is unlocking a powerful new drug development frontier. Produced by Dr. Jake Chen.

NOW PLAYING

0:00 15:44

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

Bringing it all together.

Mar 31, 2026 ·54m

Why is the vendor role so contentious in the cyber ecosystem?

Mar 27, 2026 ·14m

But what do you really want?

Mar 24, 2026 ·42m

Strategic approaches to talent: A practical guide.

Mar 20, 2026 ·42m

Mid season reflection with Kim Jones.

Mar 17, 2026 ·41m

Is the role of the CISO adding to the confusion?

Mar 13, 2026 ·44m

Similar Podcasts

Humanizing Change Tremendousness Join us each episode as we talk with innovators in their respective fields about their unique journeys and how they humanize change in their own work, right here, on Humanizing Change. AI Erik's Podcast Audio Erik Conn The AI News Podcast where we talk AI. CISO Perspectives (public) N2K Networks This season on CISO Perspectives, host Kim Jones explores some of the challenges of leading through uncertainty. We explore the complexity of the changing nature of regulation and working with the federal government, the evolution of privacy and fraud, and how emerging technologies like AI and quantum computing are changing cyber. When you don’t know what questions to ask, you’re afraid to ask, or don’t know who to ask, CISO Perspectives provides the foundation for learning in this brave new world. NEWMORROW SESSIONS - A PodCast Series on the Future of Hospitality Mario C. Bauer, Florian Schneider, Axel Weber & Dr. Tillman Bardt The Newmorrow PodCast is more than a podcast — it's a platform for open dialog on the future of our business, a platform for those building what doesn’t exist yet. Here, we share and embrace our passion for the hospitality industry, but we won’t romanticize the journey. We ask the tough questions, confront uncomfortable truths, and prepare for a future that resists easy answers. We believe that the tougher and wilder times become, the more openly, honestly and humanely people need to talk to each other and act together. We believe, openness, togetherness, and truthfulness should also be cornerstones of a professional community to develop our utopian idea of „open source“. This is a space where visionaries don’t just imagine the future — they wrestle with the paradoxes that shape it: success vs. happiness, data vs. instinct, stability vs. reinvention. Join leaders, entrepreneurs, and thinkers as they share not what made them — but what’s actively shaping them, now and next. So tune in

Frequently Asked Questions

How long is this episode of Drug Discovery AI Talk?

This episode is 15 minutes long.

When was this Drug Discovery AI Talk episode published?

This episode was published on July 25, 2025.

What is this episode about?

Can I download this Drug Discovery AI Talk episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.

URL copied to clipboard!